A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

BACKGROUND: The rapid development and distribution of SARS-CoV-2 vaccines has raised concerns surrounding vaccine safety in immunocompromised populations, such as those with inflammatory bowel disease (IBD). PURPOSE: We described adverse events (AEs) following SARS-CoV-2 vaccination in those with IB...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovinovic, A, Herauf, M, Quan, J, Hracs, L, Windsor, J W, Sharifi, N, Coward, S, Caplan, L, Gorospe, J, Ma, C, Panaccione, R, Ingram, R, Kanji, J, Tipples, G, Holodinsky, J, Berstein, C, Mahoney, D, Bernatsky, S, Benchimol, E, Kaplan, G G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991202/
http://dx.doi.org/10.1093/jcag/gwac036.170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991202/
http://dx.doi.org/10.1093/jcag/gwac036.170

Ejemplares similares